Back to Search Start Over

Promoting effect of Fe3+ on gentamicin resistance in Escherichia coli.

Authors :
Huang, Yi-feng
Li, Yi
Chen, Jie-ying
Lin, Jia-hui
Liu, Lu
Ye, Jin-zhou
Su, Yu-bin
Source :
Biochemical & Biophysical Research Communications. Oct2022, Vol. 625, p134-139. 6p.
Publication Year :
2022

Abstract

Kinds of antibiotics are used to prevent and control bacteria infections, unfortunately, the overuse and misuse of antibiotic have promoted the emergence and spread of antibiotic-resistant bacteria. Therefore, understanding the mechanism of antibiotic resistance is very important. This study explores the combined effection of metal ions and antibiotic to the drug resistance of Escherichia coli. Our results found that the minimum inhibitory concentration (MIC) increased as the ammonium ferric citrate concentration increased, especially for gentamicin antibiotic. When the Fe3+ concentration reached 300 μM, the survival of E. coli was stably restored with the increased gentamicin concentration. Exogenous Fe3+ could decrease intracellular gentamicin concentration. On the other hand, Fe3+ treatment together with gentamicin could reduce reactive oxygen species (ROS) production, characterized by decreased levels of NADH and ATP. Furthermore, ROS-scavenging enzymes of superoxide dismutase (SOD) and catalase (CAT) were up-regulated and H 2 O 2 plus gentamicin-mediated killing was restored by Fe3+. These results may have significant implications in understanding bacterial antibiotic-resistant mechanisms based on the external Fe3+ concentration. • Fe3+ enhances the resistance of gentamicin in Escherichia coli. • Fe3+ causes the decrease of intracellular gentamicin. • Fe3+ reduces ROS generation through decreasing ATP and NADH and increasing SOD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0006291X
Volume :
625
Database :
Academic Search Index
Journal :
Biochemical & Biophysical Research Communications
Publication Type :
Academic Journal
Accession number :
158744044
Full Text :
https://doi.org/10.1016/j.bbrc.2022.07.102